Management and outcomes of cardiac tamponade during atrial fibrillation ablation in the presence of therapeutic anticoagulation with warfarin

Heart Rhythm. 2011 Jun;8(6):805-8. doi: 10.1016/j.hrthm.2011.01.020. Epub 2011 Jan 12.

Abstract

Background: Cardiac tamponade (CT) is a possible complication of radiofrequency catheter ablation (RFCA) of atrial fibrillation (AF). Although the incidence of CT is not higher when RFCA is performed with a therapeutic international normalized ratio (INR), outcomes of CT are unclear.

Objective: We compared outcomes among patients with and without a therapeutic INR who developed CT as a complication of RFCA of AF.

Methods: The subjects of this retrospective study were 40 consecutive patients who developed CT during RFCA of AF at 3 centers. We divided the patients into 2 groups: RFCA performed with INR < 2 (group 1) and INR ≥ 2 (group 2). There were 23 patients in group 1 and 17 patients in group 2.

Results: Baseline clinical and procedure characteristics were not different between the 2 groups. Heparin was reversed by protamine in 83% and 94% of patients (P = .37), and warfarin was reversed by fresh frozen plasma or factor VIIa in 17% and 35% of patients (P = .27) in groups 1 and 2, respectively. All patients were successfully treated by percutaneous drainage, and none required surgical intervention. There were no significant differences in the amount of initial pericardial drainage (523 ± 349 ml vs. 409 ± 157 ml, P = .22) or the duration of drainage (P = .14) between the 2 groups. All patients survived to hospital discharge. Median length of hospital stay was 2 days longer in group 1 (P <.01).

Conclusion: Cardiac tamponade is not more severe or difficult to manage in the presence of therapeutic anticoagulation with warfarin in patients undergoing RFCA of AF.

Publication types

  • Comparative Study
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / adverse effects*
  • Anticoagulants / therapeutic use
  • Atrial Fibrillation / therapy*
  • Cardiac Tamponade / epidemiology
  • Cardiac Tamponade / etiology
  • Cardiac Tamponade / surgery*
  • Catheter Ablation / adverse effects*
  • Drainage / methods*
  • Female
  • Humans
  • Incidence
  • Intraoperative Complications
  • Male
  • Middle Aged
  • Pericardiocentesis*
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome
  • United States / epidemiology
  • Warfarin / adverse effects*
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Warfarin